GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Personal Services » Medifast Inc (NYSE:MED) » Definitions » Price-to-Owner-Earnings

Medifast (Medifast) Price-to-Owner-Earnings : 2.99 (As of Apr. 26, 2024)


View and export this data going back to 1981. Start your Free Trial

What is Medifast Price-to-Owner-Earnings?

As of today (2024-04-26), Medifast's share price is $33.50. Medifast's Owner Earnings per Share (TTM) ended in Dec. 2023 was $11.22. It's Price-to-Owner-Earnings for today is 2.99.


The historical rank and industry rank for Medifast's Price-to-Owner-Earnings or its related term are showing as below:

MED' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 2.81   Med: 22.72   Max: 64.21
Current: 2.99

During the past 13 years, the highest Price-to-Owner-Earnings of Medifast was 64.21. The lowest was 2.81. And the median was 22.72.


MED's Price-to-Owner-Earnings is ranked better than
93.48% of 46 companies
in the Personal Services industry
Industry Median: 10.75 vs MED: 2.99

As of today (2024-04-26), Medifast's share price is $33.50. Medifast's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $9.06. Therefore, Medifast's PE Ratio for today is 3.70.

As of today (2024-04-26), Medifast's share price is $33.50. Medifast's EPS without NRI for the trailing twelve months (TTM) ended in was $9.65. Therefore, Medifast's PE Ratio without NRI for today is 3.47.

During the past 13 years, Medifast's highest PE Ratio without NRI was 74.99. The lowest was 3.27. And the median was 17.22.


Medifast Price-to-Owner-Earnings Historical Data

The historical data trend for Medifast's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medifast Price-to-Owner-Earnings Chart

Medifast Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17.94 17.83 33.07 7.68 5.99

Medifast Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.68 6.03 5.39 5.12 5.99

Competitive Comparison of Medifast's Price-to-Owner-Earnings

For the Personal Services subindustry, Medifast's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medifast's Price-to-Owner-Earnings Distribution in the Personal Services Industry

For the Personal Services industry and Consumer Cyclical sector, Medifast's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Medifast's Price-to-Owner-Earnings falls into.



Medifast Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Medifast's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=33.50/11.22
=2.99

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medifast  (NYSE:MED) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Medifast Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Medifast's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Medifast (Medifast) Business Description

Traded in Other Exchanges
Address
100 International Drive, Baltimore, MD, USA, 21202
Medifast Inc is a United states based company that produces, distributes and sells products concerning weight loss, weight management, and healthy living. The company generates its revenue from point of sale transactions executed over an e-commerce platform for weight loss, weight management, and other consumable health and nutritional products.
Executives
Jeffrey J Brown director 19900 MACARTHUR BLVD, SUITE 570, IRVINE CA 92612
Andrea B Thomas director C/O MEDIFAST, INC., 100 INTERNATIONAL DRIVE, BALTIMORE MD 21202
Michael A. Hoer director MEDIFAST, INC., 100 INTERNATIONAL DRIVE, 18TH FLOOR, BALTIMORE MD 21202
Scott Schlackman director 3600 CRONDALL LANE, OWINGS MILLS MD 21117
Hallquist Constance J. director 3600 CRONDALL LANE, OWINGS MILLS MD 21117
Elizabeth A. Geary director C/O MEDIFAST, INC., 100 INTERNATIONAL DRIVE, BALTIMORE MD 21202
Daniel R Chard director, officer: Chief Executive Officer NU SKIN ENTERPRISES, INC., 75 WEST CENTER STREET, PROVO UT 84601
Jonathan Barrett Mackenzie officer: VP, Finance & CAO 100 INTERNATIONAL DRIVE, BALTIMORE MD 21202
Kevin G Byrnes director C/O MEDIFAST, INC., 3600 CRONDALL LANE, OWINGS MILLS MD 21117
Michael C Macdonald director C/O MEDIFAST, INC., 3600 CRONDALL LANE, OWINGS MILLS MD 21117
James P. Maloney officer: Chief Financial Officer 415 HOLIDAY DRIVE, PITTSBURGH PA 15220
Ming Xian director MEDIFAST, INC., 100 INTERNATIONAL DRIVE, 18TH FLOOR, BALTIMORE MD 21202
Carl E Sassano director C/O MEDIFAST, INC., 3600 CRONDALL LANE, OWINGS MILLS MD 21117
Joseph P Kelleman officer: (Interim) CFO 3600 CRONDALL LANE, OWINGS MILLS MD 21117
Timothy G Robinson officer: Chief Financial Officer C/O MEDIFAST, INC., 3600 CRONDALL LANE, OWINGS MILLS MD 21117